文献速递创伤与烧伤呼吸衰竭与机械通气重症综合管理与镇静镇痛

肋间神经冷冻消融联合肋骨骨折手术固定的院内结局

In-hospital outcomes of intercostal nerve cryoablation and surgical stabilization of rib fractures.
PubMed 文献 · J Trauma Acute Care Surg · 2022-03-22
一句话结论回顾性分析显示,肋骨骨折手术固定联合肋间神经冷冻消融(INCA)较单纯手术固定降低总吗啡毫克当量、ICU住院时间、插管率与气管切开率,并提高回家出院比例。

该回顾性分析纳入2015—2021年一家Ⅰ级创伤中心68例接受肋骨骨折手术固定(SSRF)的18岁及以上创伤患者,其中44例联合肋间神经冷冻消融(INCA),未接受INCA者为历史对照。主要终点总吗啡毫克当量在INCA组更低(p=0.002);次要终点中,INCA组ICU住院时间更短(p=0.021)、回家出院可能性更高(p=0.044)、插管率(p=0.002)和气管切开率(p=0.032)更低。肺炎发生率(p=0.106)、机械通气时长(p=0.687)和住院总时长(p=0.059)两组无差异。作者认为INCA联合SSRF可能进一步改善创伤性肋骨骨折患者的院内结局。

要点

  • 纳入68例接受SSRF的18岁及以上创伤患者,44例联合INCA,其余为历史对照。
  • INCA组总吗啡毫克当量低于对照组(p=0.002),为主要终点。
  • INCA组ICU住院时间更短(p=0.021)、回家出院可能性更高(p=0.044)。
  • INCA组插管率(p=0.002)与气管切开率(p=0.032)均低于对照组。
  • 肺炎发生率(p=0.106)、机械通气时长(p=0.687)、住院总时长(p=0.059)两组无差异。

适用人群与场景

  • 2015—2021年一家Ⅰ级创伤中心接受SSRF的18岁及以上创伤患者。
  • INCA由外科医生根据对操作的熟悉程度及无禁忌证决定是否施行;未接受INCA者为历史对照组。

处置流程与药物剂量

  • 在SSRF基础上联合肋间神经冷冻消融(INCA),具体冷冻神经与固定肋骨数目原文报告为纳入数据,未给出操作方案细节。

研究设计与关键结果

  • 研究类型为回顾性分析,单家Ⅰ级创伤中心,2015—2021年,共68例,44例接受INCA。
  • 主要终点总吗啡毫克当量:INCA组低于对照组(p=0.002)。
  • 次要终点:INCA组ICU住院时间更短(p=0.021)、回家出院可能性更高(p=0.044)、插管率更低(p=0.002)、气管切开率更低(p=0.032)。
  • 肺炎发生率(p=0.106)、机械通气时长(p=0.687)、住院总时长(p=0.059)两组无显著差异。
  • 长期结局随访至6个月,评估不良事件。

证据类型、等级与局限

  • 证据类型:回顾性分析(治疗/管理类),证据等级 Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,INCA联合SSRF可能进一步改善创伤性肋骨骨折患者的院内结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Severe pain and pulmonary complications commonly follow rib fractures, both of which may be improved by surgical stabilization of rib fractures (SSRFs). However, significant postoperative pain still persists which may negatively impact in-hospital outcomes. Combining intercostal nerve cryoablation (INCA) with SSRF may improve those outcomes by further decreasing postoperative pain, opioid consumption, and pulmonary complications. The hypothesis is that INCA plus SSRF reduces opioids consumption compared with SSRF alone.

METHODS: The retrospective analysis included trauma patients 18 years or older who underwent SSRF, with or without INCA, in a Level I trauma center between 2015 and 2021. Patients received INCA at the surgeons' discretion based on familiarity with the procedure and absence of contraindications. Patients without INCA were the historical control group. Reported data include demographics, mechanism and severity of injury, number of ribs stabilized, cryoablated nerves, intubation rates and duration of mechanical ventilation. The primary outcome was total morphine milligrams equivalent consumption. Secondary outcomes were intensive care unit length of stay, hospital length of stay, incidence of pneumonia, and tracheostomy rates, and discharge disposition. Long-term outcomes were examined up to 6 months for adverse events.

RESULTS: Sixty-eight patients were included, with 44 receiving INCA. There were no differences in rates of pneumonia ( p = 0.106) or duration of mechanical ventilation ( p = 0.687), and hospital length of stay was similar between groups ( p = 0.059). However, the INCA group demonstrated lower total morphine milligrams equivalent ( p = 0.002), shorter intensive care unit length of stay ( p = 0.021), higher likelihood of home discharge ( p = 0.044), and lower rate of intubation ( p = 0.002) and tracheostomy ( p = 0.032).

CONCLUSION: Combining INCA with SSRF may further improve in-hospital outcomes for patients with traumatic rib fractures.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Fernandez CA, Narveson JR, Niu F, et al. In-hospital outcomes of intercostal nerve cryoablation and surgical stabilization of rib fractures. J Trauma Acute Care Surg. 2022. PMID: 35319546. doi:10.1097/TA.0000000000003623

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。